Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen...
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)
About this item
Full title
Author / Creator
Nishina, Tomohiro , Boku, Narikazu , Gotoh, Masahiro , Shimada, Yasuhiro , Hamamoto, Yasuo , Yasui, Hirofumi , Yamaguchi, Kensei , Kawai, Hiroki , Nakayama, Norisuke , Amagai, Kenji , Mizusawa, Junki , Nakamura, Kenichi , Shirao, Kuniaki , Ohtsu, Atsushi , The Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group and Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group
Publisher
Tokyo: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer Japan
Subjects
More information
Scope and Contents
Contents
Background
This randomized phase II study compared weekly administration of paclitaxel (wPTX) with the best available 5-fluorouracil (5-FU) regimen as second-line treatment for advanced gastric cancer patients with severe peritoneal metastasis refractory to fluoropyrimidine.
Methods
In the best available 5-FU arm, continuous infusion of 5-...
Alternative Titles
Full title
Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)
Authors, Artists and Contributors
Author / Creator
Boku, Narikazu
Gotoh, Masahiro
Shimada, Yasuhiro
Hamamoto, Yasuo
Yasui, Hirofumi
Yamaguchi, Kensei
Kawai, Hiroki
Nakayama, Norisuke
Amagai, Kenji
Mizusawa, Junki
Nakamura, Kenichi
Shirao, Kuniaki
Ohtsu, Atsushi
The Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group
Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1797257079
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1797257079
Other Identifiers
ISSN
1436-3291
E-ISSN
1436-3305
DOI
10.1007/s10120-015-0542-8
